Study procedural characteristics
| Baseline NIHSS (median (IQR)) | 15 (9.5–19) |
| Intravenous rt-PA (n (%)) | 18 (85.7) |
| Carotid disease (n (%)) | |
| Occlusion | 10 (47.6) |
| Stenosis | 11 (52.4) |
| Site of intracranial occlusion (n (%)) | |
| M1 | 15 (71.4) |
| M2 | 6 (28.6) |
| Side of occlusion (n (%)) | |
| Left | 13 (61.9) |
| Right | 8 (38.1) |
| Procedure time (min) (mean±SD) | 82.5±82 |
| Casper-RX stent | |
| Single (n) | 18 |
| Multiple (n) | 3 |
| Stent diameter (mm) (median (IQR)) | 8 (6.5-8) |
| Stent length (mm) (median (IQR)) | 30 (30-30) |
| Residual stent stenosis (mean±SD) | 16.5±11 |
| Acute in-stent thrombus formation (n (%)) | 11 (52.4) |
| Incomplete vessel wall apposition (n (%)) | 1 (4.8) |
| Complications (n (%)) | |
| Emboli to ACA | 3 (14.3) |
| Vessel perforation | 1 (4.8) |
ACA, anterior cerebral artery; NIHSS, National Institutes of Health Stroke Scale; rt-PA, recombinant tissue plasminogen activator.